Understanding these medication-specific challenges allows healthcare providers to implement proactive nutritional strategies
Eric Topol, Jordan Shlain, John Battelle, David Barzilai, Jessica S., Dave Ricks, Richard Barker, Brooks Leitner, Elliot Hershberg, Phil Newman, Alex Colville To view or add a comment, sign in Eosinophilic esophagitis (EoE) is a chronic type 2 inflammatory esophageal disease driven by interleukin 13 (IL-13)
Jordan Wright, an endocrinologist and assistant professor of medicine at Vanderbilt University Medical Center
The FDA has not approved topiramate for weight loss but the medication is used off-label for weight management
Joint discomfort may result from indirect factors such as rapid weight loss altering biomechanical loading, nutritional deficiencies from reduced caloric intake, changes in physical activity patterns, or coincidental conditions like osteoarthritis common in the patient demographic